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Purpose: The main objective of this prospective study was to obtain a better understanding of the body
composition and vital sign measures of cancers survivors (CS) when compared to regular (R) patients.
Methods: A total of 9,315 female patients were evaluated: 476 CS and 8,839 R patients. Kinesiologists worked side
by side with the medical/oncology team to collect a number of base-line measurements on body composition,
resting heart rate, and blood pressure as part of the standard intake evaluation during the female patients’ annual
checkup.
Results: CS were more likely to have a higher BMI (P = 0.001) and a larger waist circumference (P = 0.001) than R
patients. CS were also shown to have higher blood pressure values: diastolic pressure of 76.9 mmHg ± 10.5 VS
75.5 mmHg ± 9.9, (P = 0.01) and systolic pressure of 129.8 mmHg ± 17.2 VS 126.7 mmHg ±17.4 (P = 0.001)
compared to R patients, respectively. Regression analysis looking at the relationship between mean arterial
pressure and waist circumference did not show any difference between the two groups (CS vs R).
Conclusion: CS who had a higher BMI, a larger waist circumference and higher blood pressure levels, are
probably at greater risk for developing cardiovascular disease, diabetes, various musculoskeletal problems as well
as an increased risk for various forms of cancers including reoccurrence of previously treated cancer when
compared to R patients. Changes in body composition should be considered by the medical team when looking
at preventative healthcare strategies for their CS patients.
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It has been well established that as body composition
changes with an increase in waist circumference and an
overall increase in body mass index (BMI), there is a
greater risk for individuals to develop various metabolic
diseases such as diabetes, heart disease, as well as an in-
creased risk of developing cancer or having a reoccur-
rence of a previously treated cancer (Han et al. 2006).
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in any medium, provided the original work is pOrganization (WHO), have recognized the importance
of physical activity, maintaining ideal body size, improv-
ing dietary habits and ceasing smoking in order to re-
duce the risk of developing various metabolic diseases
(Harvie et al. 2005). Unfortunately even with these
guidelines, many people still present with increases in
total body fat, increases in BMI, as well as reduced fit-
ness levels (Flegal et al. 2010).
Numerous studies have looked at the relationship be-
tween changes in body composition and vital sign mea-
sures and the increase in risk for developing various
diseases. Most of these studies, however, have had to rely
on patients self-reporting their values or have had to rely
on data extraction from records kept at multiple locationsOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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composition values such as body weight and body fat
(Battaglini et al. 2011; Blair et al. 2012). Other investi-
gators have used meta-analysis to evaluate the impact
of risk and body composition (Carmichael and Bates
2004). Thus, we hypothesized that by measuring body
composition and vital signs in women as part of their
regular follow-up care and comparing the Cancer Sur-
vivors (CS) to the Regular Patients (R) that we would
be able to obtain a better understanding of the poten-
tial increase of ill health risk that cancer patients face
after completing therapy. The main objective of this
prospective study was to obtain a better understanding
of the body composition and vital sign measures of CS
when compared to R.
Methodology
All participants were recruited at the VM medical centre
(VMMC). As a patient in the VMMC system, patients
were encouraged to read over and consider signing a
consent form so that data collected by the medical team
could be analyzed for trends. All of the data that was
collected and passed over to the research team was an-
onymous. The consent form was approved for usage by
the VMMC ethics committee and conforms to the Helsinki
declaration on research on human subjects.
A protocol was developed in-house that encouraged
patients, waiting for their annual medical appointments,
to undergo body composition and blood pressure mea-
surements that once collected would be entered into the
centre’s electronic charting system. All of the tests were
administered by licensed and experienced kinesiologists
who were comfortable working with special populations.
The information collected on each patient was made ac-
cessible to their physician so that they may have a better
understanding of some of the patient’s health challenges.
A testing room was set up close to the patient waiting
area at the VMMC. Patients were brought to the testing
room and given an over view of the type of tests that
would be performed. This period of time allowed the pa-
tients to relax and ask any questions before testing began.
An automated blood pressure cuff (Physiologic Auto-
memory 90, Montreal, Canada) was used to measure rest-
ing heart rate and blood pressure (BP). Most patients were
tested on their left arm, unless they were oncology pa-
tients who had undergone breast surgery along with
lymph node removal on their left side. These patients
were tested using their right arm. All BP measurements
were performed with the forearm supported at heart level
with an appropriate size cuff wrapped around the patient’s
upper arm. The cuff was aligned with the brachial artery.
The kinesiologists followed the Canadian guidelines when
applying and recording measurements. If the measure-
ments were considered outside of the expected values forthat patient (based on their age) the patient would relax
for 5 minutes after which the test was repeated. This is
consistent with the Canadian Heart and Stroke Founda-
tion Guidelines (Hypertension Canada 2013).
The patient was then asked to stand in front of a sta-
diomometer (Health O Meter, McCook, IL, USA) for
measuring height. Briefly, it consisted of a vertical ruler
with a sliding horizontal rod that was adjusted so that it
would rest on the top of the head while the participant
would take in a full breath and hold for several seconds
while the measured height was recorded. Total body
weight was recorded with a floor scale (Am Cells, Rice
Lake weight scales, Rice Lake Wisconsin, USA).
The waist was measured following ACSM guidelines
(American College of Sports Medicine 2009). Waist cir-
cumference was measured using a Gulick tape (Heart and
Stroke Foundation, Ottawa, ON, Canada). Waist measure-
ment was performed with the patient standing upright,
feet together, and arms at their side while maintaining a
relaxed breathing pattern. A horizontal measure was taken
at the narrowest location between the umbilicus and the
sternum. The test was repeated two times and the average
was taken. If there was a difference of more than 5 milli-
meters between measurements, a third measurement was
taken.
For this study patients were classified as either being
CS or R. All of the women classified as CS underwent ei-
ther a partial or a full mastectomy, which possibly included
additional forms of adjuvant therapy. The additional ther-
apies may have included chemotherapy, radiotherapy and
hormonal therapy. Some patients may have had only one
additional therapy while other patients may have had two
or three different forms of adjuvant therapy. Patients clas-
sified as R would not have had any of the adjuvant therap-
ies listed above. Both the CS and the R may also have had
other health issues and were taking additional medication
that may have affected outcome measurements.
Data analysis
Statistical analysis was performed using IBM SPSS Statis-
tics (Version 19.0). Simple unpaired t-tests were per-
formed on dependent variables between groups (CS vs R).
Pearson correlation was used to evaluate relationships be-
tween outcomes measures. Regression analysis was per-
formed using Sigma Plot for Windows (Version 11.0).
Statistical significance was set at p < .05.
Results
A total of 9,315 female patients were evaluated: 476 CS
patients and 8,839 R patients. The mean age of the patients
was significantly different being CS = 59.71 ± 9.93 yrs. and
R = 55.81 ± 9.90 yrs. (p = 0.00).
A total 338 CS patients had a partial mastectomy, 62
CS patients had a full mastectomy, 54 CS patients had
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cal intervention was unclear. The right side was the sur-
gically affected side for 213 CS patients, left side was the
surgically affected side for 239 CS patients, 19 CS pa-
tients had both sides affected and for 5 of the CS pa-
tients the affected side was unclear.
Surgery was the only intervention for 35 CS patients,
7 CS patients had surgery along with chemotherapy, 32
CS patients had surgery along with radiotherapy, 49 CS
patients had surgery along with hormone therapy and
345 CS patients had surgery along with multiple forms
of therapy, which included combinations of chemotherapy,
radiotherapy and hormonal therapy. For 9 CS patients the
treatment was not clearly indicated.
Significant differences between CS and R in the following
outcome measures are shown in Table 1, where Diastolic
pressure: CS = 76.9 ± 10.53 VS R = 75.5 ± 9.91 mmHg
(p = 0.014), Systolic pressure: CS = 129.8 ± 17.18 VS R =
126.7 ± 17.42 mmHg (p = 0.001). Mean Arterial Pressure
CS = 93.72 ± 14.27 R = 92.14 ± 12.85 (p = 0.001). BMI:
CS = 26.99 ± 5.14 VS R = 25.97 kg/m2 ± 5.61 (p = 0.000)
and waist circumference CS = 88.44 ± 11.83 VS R = 86.29 ±
11.98 cm (P = 0.000). Resting heart rate was not signifi-
cantly different between the two groups: CS = 73.25 ± 12.82
VS R = 73.32 ± 11.91 bpm (p = 0.112).
As shown in Tables 2 and 3, patients were stratified ac-
cording to 10-year age segments from 20–29 years to 80–
89 years. At each end of the stratification there were only
a few patients in the CS group: 1 patient in the 20–29 year,
7 patients in the 30–39 year range and 5 patients in the
80–89 year range. According to age groups, significant dif-
ferences were seen in the diastolic blood pressure for the
40–49 and the 50–59 age groups (p = 0.00 and p = 0.01,
respectively), as well as significant differences for weight,
BMI and waist circumference in the 50–59 age range
(p = 0.00, p = 0.03 and p = 0.05, respectively). In the
80–89 age group, the CS group diastolic and systolic
blood pressure and the waist circumference were allTable 1 Anthropometric and vital signs comparison
between all regular patients and all cancer survivors
R n = 8839 CS n = 476 p
Diastolic BP (mmHg) 75.52 (9.91) 76.85* (10.53) 0.01
Systolic BP (mmHg) 126.70 (17.42) 129.83* (17.18) 0.00
Mean arterial pressure (mmHg) 92.14 (12.85) 93.72* (14.27) 0.01
Resting heart rate (bpm) 72.32 (11.91) 73.85 (12.82) 0.10
Weight (kg) 67.49 (13.71) 68.97* (13.54) 0.02
Height (cm) 161.18 (6.76) 159.64* (6.41) 0.00
BMI 25.97 (5.61) 26.99* (5.14) 0.00
Waist circumference (cm) 86.29 (11.98) 88.44* (11.83) 0.00
Mean ± (SD), *significantly different to R (indicated in p column), CS = cancer
survivors, R = regular patients.significantly less (p = 0.01, p = 0.02 and p = 0.04, re-
spectively) in comparison to the R patients.
In general, all CS showed an apparent trend for a
higher body weight, BMI and waist circumference when
compared to the R patients.
Regression analysis using mean arterial pressure and
waist circumference was performed (Figure 1). Significant
correlations in the CS and R groups were observed between
MAP values and waist circumference values (r = 0.16,
p = .001 and r = 0.29, p = .001, respectively).
Discussion
The CS patients in most of the variables measured were
shown to be significantly different from the R patients,
with the CS having potentially higher levels of total body
fat, a higher BMI and greater waist circumferences. The
CS diastolic and systolic blood pressure values were also
significantly greater in comparison to the R patients.
Cancer survivors face many challenges as they undergo
adjuvant therapy as part of cancer treatment strategies
(Yerushalmi et al. 2009). Some studies have shown that
treatment has limited to no effect on blood pressure
(Stergiou et al. 2002), while other studies have shown
that adjuvant therapy may cause significant changes in
body composition and elevated blood pressure (Emaus
et al. 2010; Thomson et al. 2009). In fact, in the present
study, systolic blood pressure for all CS, except for
the 30-39 age group (119.14 ± 7.86 mmHg, Table 2)
would be classified as pre-hypertensive with values over
120 mm Hg according to ACSM guidelines (American
College of Sports Medicine 2013).
The elevated blood pressure may have been related to
the adjuvant therapy received by the women. Hormone
therapy has been shown to elevate blood pressure in
women (Braddock et al. 2013). It is highly likely that
some of the patients in the CS group did take hormone
replacement medication as part of their adjuvant ther-
apy. Our results on blood pressure are similar to those
recently reported by Braddock et al. (2013) that have
shown that both medication, including chemotherapy,
and other adjuvant therapies (radiotherapy) had an effect
on blood pressure (Braddock et al. 2013).
Waist circumference
It has been shown in peri-menopausal and menopaused
women that the level of estrogen in the body decreases
(Blume-Peytavi et al. 2012; Feigelson et al. 2006). This
drop in estrogen has been shown to be linked with an
increase in visceral fat (Feigelson et al. 2006). We were
able to see this increase in waist circumference in both
the CS and R patients. The R patients’ mean waist cir-
cumference increased from 81.8 ± 10.42 cm at 30–
40 years of age to 89.5 ± 12.27 cm at 70–79 years of age,
while in the CS group the mean waist circumferences
Table 2 Anthropometric and vital signs measures stratified by 10 yr. age groups (20 to 59 yrs.) for Regular (R) and
Cancer Survivors (CS) patients
















Mean weight (kg) SD 57.69 (11.32) 57.00 (0.00) 65.14 (13.25) 67.08 (7.26) 67.00 (14.30) 67.23 (14.22) 67.73 (13.86) 70.91* (14.87)
Mean BP diastolic
(mmHg) SD
69.70 (5.68) 76.00 (0.00) 71.92 (8.80) 78.14 (9.75) 74.68 (9.89) 78.17* (10.76) 76.14 (9.79) 78.27* (9.92)
Mean BP systolic
(mmHg) SD
113.00 (10.51) 129.00 (0.00) 115.65 (11.48) 119.14 (7.86) 119.94 (14.72) 121.33 (16.51) 125.36 (15.77) 127.57 (15.07)
Mean arterial pressure
(mmHg) SD
76.48 (26.15) 93.76 (0.00) 86.50 (8.94) 91.81 (8.94) 89.34 (12.32) 92.56* (11.76) 92.68 (12.61) 93.35 (15.43)
Mean heart rate
(BPM) SD
78.50 (12.64) 79.00 (0.00) 73.46 (11.34) 71.86 (12.08) 72.22 (11.83) 72.37 (13.63) 72.17 (11.96) 74.06 (12.29)
Mean BMI SD 21.28 (3.47) 21.20 (0.00) 24.28 (5.28) 25.79 (3.68) 25.19 (5.52) 25.48 (5.32) 25.96 (5.60) 27.01 (5.57)
Waist circumference
(cm) SD
74.40 (6.07) 76.00 (0.00) 81.82 (10.42) 85.39 (6.96) 83.79 (11.79) 86.02 (11.55) 86.12 (11.85) 88.14* (7.48)
Significance set P < 0.05, Standard deviation = SD, *Significant difference between CS and R with CS being significantly greater than R values.
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90.00 ± 9.53 cm at 70–79 years of age. Waist circumfer-
ences were consistently larger for the CS group com-
pared to the R patients except at age 80–89. When
evaluating the patient’s weight in relation to their height
and their age many of the patients could be considered
overweight based on BMI charts (American College of
Sports Medicine 2013).
It is well recognized that limited information may be
determined through the use of BMI. BMI is a measure-
ment that many physicians use to evaluate a patient’s
body composition (Ahn et al. 2012). Therefore it is im-
portant to link BMI with additional measurements such
as waist circumference (American College of Sports
Medicine 2013) to help physicians obtain a better under-
standing of the patient’s health through the use of body
composition measurements. The BMI values obtained
on the patients in this study showed that many of the
women were not falling into the recommended guide-
lines put forward by the ACSM (American College of
Sports Medicine 2009). The ACSM does make recom-
mendations on waist circumference and BMI and strati-
fies people according to age group (20–29 yrs, etc.). WeTable 3 Anthropometric and vital signs measures stratified b
Cancer Survivors (CS) patients
Outcome measure R 60–69 n = 2184 CS 60–69 n = 162
Mean weight (kg) SD 68.36 (13.16) 68.83 (12.48)
Mean BP diastolic (mmHg) SD 76.23 (9.79) 76.24 (10.95)
Mean BP systolic (mmHg) SD 132.41 (18.36) 133.54 (17.16)
Mean arterial pressure (mmHg) SD 94.53 (13.15) 94.76 (14.11)
Mean heart rate (BPM) SD 72.79 (11.88) 73.21 (13.65)
Mean BMI SD 26.66 (5.37) 27.46 (4.90)
Waist circumference (cm) SD 88.47 (11.70) 89.39 (12.85)
Significance set P < 0.05, Standard deviation = SD, **Significant difference betweenobserved with both the R and CS patients that their
values exceeded the recommended guidelines. As well,
there was a small effect of waist circumference increase
on mean arterial pressure in CS patients (see Figure 1).
In contrast, the increase in waist circumference in R pa-
tients appears to have a markedly greater effect on mean
arterial pressure. This would also mean that in the lower
waist circumference range the mean arterial pressure
difference between CS and R patients was larger with
the difference becoming smaller as waist circumference
increased. A possible explanation for this difference may
be associated with treatment the patient underwent
(Braddock et al. 2013). It has been shown that various
medication types on oncology patients increases the
amount of cardiovascular stress on the body (Stergiou
et al. 2002). The differences seen in blood pressure and
resting heart rate, however, may have been present be-
fore treatment.
Strength of study
Having all women tested by the same team members
utilizing the same protocol gives significant strength to
this study. The approach used herein contrasts twoy 10 yr. age groups (60 to 89 yrs.) for Regular (R) and
R 70–79 n = 753 CS 70–79 n = 82 R 80–89 n = 102 CS 80–89 n = 5
66.97 (12.83) 68.29 (11.98) 62.71 (12.24) 63.44 (6.81)
74.85 (10.09) 75.16 (9.90) 74.42 (10.58) 62.60** (9.84)
138.24 (17.67) 135.56 (17.95) 143.73 (16.43) 126.00** (16.93)
95.47 (13.05) 94.14 (15.24) 97.52 (10.75) 83.73** (11.76)
71.42 (12.07) 72.74 (11.50) 72.37 (12.15) 74.80 (13.55)
26.95 (5.99) 27.81 (4.81) 26.64 (7.12) 24.48 (2.13)
89.53 (12.27) 90.00 (9.53) 90.41 (11.72) 84.86** (4.25)
CS and R with CS being significantly less than R values.
Figure 1 Relationship between mean arterial pressure and
waist circumference in Regular (R) and Cancer Survivor
(CS) patients.
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reporting and the second the use of multiple test sites
with multiple teams. From the literature (Dahl and
Reynolds 2013), it is known that patients tend to under-
estimate their weight. The use of patient’s self –reporting
data, in particular their own body weight would have in-
creased the amount of error in the data that was collected.
A large number of patients participated in this project,
just over 9300 women. This is equivalent to other stud-
ies using multiple testers and multiple locations (Han-
sen et al. 1997). The more locations and the more
testers involved in the testing process the greater the
risk of error. With three kinesiologists performing all of
the measurements we are confident we have minimized
some of the intra and inter tester error that could have
occurred.
It would be interesting to see the effects of an inter-
vention, such as counseling, while tracking these two
groups over time to see if the patients’ body composition
and blood pressure would improve. Without any inter-
vention, it would be expected that both body compos-
ition and blood pressure values would continue to move
in a negative direction as both the CS and R patients
aged, with the CS potentially being more affected.
Limitations of the study
One factor that may have affected vital sign measure-
ments could have been the stress of going to the physi-
cian's office for the CS. We speculated that it may have
been more stressful for the CS because they were seeing
their surgical oncologist as part of an ongoing follow up.
The CS patient’s fear of hearing about a possible re-
occurrence may have elevated their BP values. On theother hand, the R patients were typically visiting the
clinic for an appointment with their GP or their OBGYN
as part of their routine yearly evaluation. A second limi-
tation of this study is the homogeneity of the population.
There was limited diversity in the population that was
tested. Even though it was not specifically recorded most
of the women tested were Caucasian and only a small
portion of the patients at the VMMC were from another
ethnic group. However, the homogeneity of the study
population herein may also be considered strength. We
recognize that it would have been helpful to have add-
itional information on the patients such as the type of
medication that the patients may be ingesting. This con-
founding variable may influence the outcome measures
that were collected on patients in our study. We also
understand some of the challenges with collecting this
information, such as the level of compliance by the pa-
tients in taking medication (Thunander Sundbom and
Bingefors 2012), which has been found to be affected by
gender and socioeconomic status. Some association may
be drawn from the stratification of the patients by age
with the expectation that a number of women in both
groups will encounter similar health related issue that
are associated with age, such as increased risk of osteo-
porosis (Siris et al. 2014).Future directions
Understanding body composition and fitness level has
been shown to be strong markers at identifying cancer
risk (Kruk and Aboul-Enein 2006). Future studies should
incorporate the use of measurement tools, such as im-
pedance units, fat calipers or DEXA for body compos-
ition assessment to provide more detailed information
about body fat and lean muscle mass. Detailed body
composition give a better understanding of body com-
position of cancer survivors. Nonetheless, using simple
vital signs measurements, taken by kinesiologists appears
to be sensitive enough to identify individuals at risk. Be-
ing able to incorporate the fitness level and activity level
of the cancer survivors might also improve sensitivity
and may prove important.Conclusion
The baseline risk assessment protocol established at the
VMMC and administered by kinesiologists is critical in
helping to understand some of the fundamental risks
faced by patients. The protocol used by the VMMC
Kinesiologists, who were working in conjunction with
the medical team at the centre, gave the patients a clear
starting point as to some of behavior changes to be
adopted by the patient to help reduce their risk of devel-
oping different forms of cancer, cardiovascular issues
and metabolic diseases.
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